• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Orbit International Corp.

  • ID: 622091
  • March 2015
  • Region: Global
  • 56 Pages
  • Wright Investors Service

A textual analysis of the financial results for Orbit International Corp. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Orbit International Corp.. There is a textual review of the financial results of Orbit International Corp. and three of its industry peers. . The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

United States

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Dundee Precious Metals Inc. - Product Thumbnail Image

    Dundee Precious Metals Inc.

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Orbit Corporation Limited - Product Thumbnail Image

    Orbit Corporation Limited

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM
  • LGL Group Inc - Product Thumbnail Image

    LGL Group Inc

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM
  • Orbit Communications - Product Thumbnail Image

    Orbit Communications

    • Language: English
    • 55 Pages
    • Published: March 2015
    FROM
  • Orbit Garant Drilling Incorporated - Product Thumbnail Image

    Orbit Garant Drilling Incorporated

    • Language: English
    • 53 Pages
    • Published: March 2015
    FROM
  • Jaguar Mining Incorporated - Product Thumbnail Image

    Jaguar Mining Incorporated

    • Language: English
    • 55 Pages
    • Published: March 2015
    FROM
  • Orbit Exports Limited. - Product Thumbnail Image

    Orbit Exports Limited.

    • Language: English
    • 54 Pages
    • Published: March 2015
    FROM
  • Gupta Synthetics Limited - Product Thumbnail Image

    Gupta Synthetics Limited

    • Language: English
    • 54 Pages
    • Published: March 2015
    FROM
  • Espey Mfg. & Electronics Corp. - Product Thumbnail Image

    Espey Mfg. & Electronics Corp.

    • Language: English
    • 55 Pages
    • Published: March 2015
    FROM
  • Wesdome Gold Mines Ltd - Product Thumbnail Image

    Wesdome Gold Mines Ltd

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.